Optune(ttfields) device: 90 day initial
Ended Awarded
- Contract number
- 36C25026F0232
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,749
Award facts
- Contract value 100% obligated
- $49,748.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a delivery order to Novocure Inc. on January 20, 2026, valued at $49,748.73 for a 90-day initial provision of Optune Tumor Treating Fields (TTFields) devices. This delivery order, structured as a firm fixed-price contract with no set-aside designation, will be performed at the Portsmouth, New Hampshire VA medical facility and is scheduled for completion by April 7, 2026. Novocure Inc., a medical device manufacturer specializing in non-invasive cancer treatment technologies, serves as the prime contractor with no subcontractor involvement, ensuring direct quality control over its proprietary TTFields systems.
This delivery order is issued under Novocure's parent Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, a multiple-award agreement valued at $28.85 million through October 31, 2027. The FSS contract, established November 1, 2022, has enabled the VA to streamline procurement and issue over 100 delivery orders across Veterans Integrated Service Networks nationwide. Through this vehicle, Novocure has emerged as the primary source provider of Optune devices and transducer components, facilitating the Veterans Health Administration's strategic objective to expand veterans' access to innovative, non-invasive cancer treatment options for solid tumors, including FDA-approved applications for glioblastoma and mesothelioma.
Quick answers
Who was awarded contract 36C25026F0232?
36C25026F0232 was awarded to Novocure Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 20, 2026.
How much is contract 36C25026F0232 worth?
The government has obligated $49,749 on 36C25026F0232.
Is contract 36C25026F0232 an order under another contract?
Yes. 36C25026F0232 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C25026F0232 competed?
The extent of competition for 36C25026F0232 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award